Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum
- PMID: 772922
Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum
Abstract
All of these experiments demonstrate that despite many microbiologic differences between Pseudomonas and the enteric rods, there is a close immunologic relationship between their endotoxin cores. These studies also show that by genetic manipulation we can unmask a protective antigen for preparing antiserum with a broad range of activity, even in the face of neutropenia. Production of potent human J5 antiserum is a safe, simple procedure, making it possible to consider endotoxin core antibody treatment of all Gram negative bacteremia in patients regardless of the causative organism.
Similar articles
-
Ineffectiveness of single-dose human antiserum to core glycolipid (E. coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutropenia.Schweiz Med Wochenschr Suppl. 1983;14:40-5. Schweiz Med Wochenschr Suppl. 1983. PMID: 6361990 Clinical Trial.
-
Antiserum treatment of gram-negative bacteremia.Schweiz Med Wochenschr. 1978 Dec 2;108(48):1872-6. Schweiz Med Wochenschr. 1978. PMID: 362528 Review.
-
Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota.Ann Immunol (Paris). 1982 Jul-Aug;133D(1):71-6. Ann Immunol (Paris). 1982. PMID: 6760795
-
Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.J Infect Dis. 1977 Aug;136 Suppl:S167-73. doi: 10.1093/infdis/136.supplement.s167. J Infect Dis. 1977. PMID: 330776
-
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.Prog Clin Biol Res. 1991;367:141-59. Prog Clin Biol Res. 1991. PMID: 1924424 Review.
Cited by
-
Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.Eur J Clin Microbiol. 1985 Apr;4(2):180-5. doi: 10.1007/BF02013594. Eur J Clin Microbiol. 1985. PMID: 3924605
-
Neutralization of meningococcal endotoxin by antibody to core glycolipid.J Exp Med. 1978 Apr 1;147(4):1007-17. doi: 10.1084/jem.147.4.1007. J Exp Med. 1978. PMID: 418134 Free PMC article.
-
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.J Clin Invest. 1982 Apr;69(4):742-9. doi: 10.1172/jci110512. J Clin Invest. 1982. PMID: 7042755 Free PMC article.
-
Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.Infect Immun. 1986 Aug;53(2):298-304. doi: 10.1128/iai.53.2.298-304.1986. Infect Immun. 1986. PMID: 3525407 Free PMC article.
-
Characterization of murine monoclonal antibodies to Escherichia coli J5.Infect Immun. 1986 Apr;52(1):56-62. doi: 10.1128/iai.52.1.56-62.1986. Infect Immun. 1986. PMID: 3514463 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources